315 related articles for article (PubMed ID: 26063050)
1. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.
Leroux S; Turner MA; Guellec CB; Hill H; van den Anker JN; Kearns GL; Jacqz-Aigrain E; Zhao W;
Clin Pharmacokinet; 2015 Dec; 54(12):1273-85. PubMed ID: 26063050
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.
Zhao W; Hill H; Le Guellec C; Neal T; Mahoney S; Paulus S; Castellan C; Kassai B; van den Anker JN; Kearns GL; Turner MA; Jacqz-Aigrain E;
Antimicrob Agents Chemother; 2014 Nov; 58(11):6572-80. PubMed ID: 25155587
[TBL] [Abstract][Full Text] [Related]
3. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
4. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.
Leroux S; Roué JM; Gouyon JB; Biran V; Zheng H; Zhao W; Jacqz-Aigrain E
Antimicrob Agents Chemother; 2016 Nov; 60(11):6626-6634. PubMed ID: 27572399
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin Pharmacokinetics in Clinical Canine Patients.
Papich MG
J Vet Intern Med; 2017 Sep; 31(5):1508-1513. PubMed ID: 28771831
[TBL] [Abstract][Full Text] [Related]
6. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.
Forrest A; Ballow CH; Nix DE; Birmingham MC; Schentag JJ
Antimicrob Agents Chemother; 1993 May; 37(5):1065-72. PubMed ID: 8517693
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P
Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method.
Wang J; Liang WQ; Wu JJ; Pan CM
Acta Pharmacol Sin; 2000 Oct; 21(10):954-60. PubMed ID: 11501052
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of intravenous and oral ciprofloxacin in children to optimize dosing regimens.
Hirt D; Oualha M; Pasquiers B; Blanot S; Rubinstazjn R; Glorion C; Messaoudi SE; Drummond D; Lopez V; Toubiana J; Béranger A; Boujaafar S; Zheng Y; Capito C; Winter S; Léger PL; Berthaud R; Gana I; Foissac F; Tréluyer JM; Bouazza N; Benaboud S
Eur J Clin Pharmacol; 2021 Nov; 77(11):1687-1695. PubMed ID: 34160669
[TBL] [Abstract][Full Text] [Related]
11. Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation.
Thuo N; Ungphakorn W; Karisa J; Muchohi S; Muturi A; Kokwaro G; Thomson AH; Maitland K
J Antimicrob Chemother; 2011 Oct; 66(10):2336-45. PubMed ID: 21831986
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients.
Abdulla A; Rogouti O; Hunfeld NGM; Endeman H; Dijkstra A; van Gelder T; Muller AE; de Winter BCM; Koch BCP
Eur J Clin Pharmacol; 2020 Jul; 76(7):957-967. PubMed ID: 32307575
[TBL] [Abstract][Full Text] [Related]
14. Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
Roger C; Wallis SC; Louart B; Lefrant JY; Lipman J; Muller L; Roberts JA
J Antimicrob Chemother; 2016 Jun; 71(6):1643-50. PubMed ID: 26957490
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of ciprofloxacin in pediatric and adolescent patients with acute infections.
Payen S; Serreau R; Munck A; Aujard Y; Aigrain Y; Bressolle F; Jacqz-Aigrain E
Antimicrob Agents Chemother; 2003 Oct; 47(10):3170-8. PubMed ID: 14506027
[TBL] [Abstract][Full Text] [Related]
16. Variability of ciprofloxacin pharmacokinetics in children: impact on dose range in sickle cell patients.
Facchin A; Bui S; Leroux S; Nacka F; Koehl B; Maksoud E; Fayon M; Jacqz-Aigrain E;
J Antimicrob Chemother; 2018 Dec; 73(12):3423-3429. PubMed ID: 30203024
[TBL] [Abstract][Full Text] [Related]
17. Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.
Chen Y; Lu J; Dong M; Wu D; Zhu Y; Li Q; Chen C; Li Z
Eur J Clin Pharmacol; 2016 Dec; 72(12):1479-1488. PubMed ID: 27644691
[TBL] [Abstract][Full Text] [Related]
18. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants.
Tang BH; Wu YE; Kou C; Qi YJ; Qi H; Xu HY; Leroux S; Huang X; Zhou Y; Zheng Y; Jacqz-Aigrain E; Shen AD; Zhao W
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509939
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in Teddy goats.
Iqbal Z; Javed I; Basit A; Jan I; Khan AA
Pak J Pharm Sci; 2011 Jan; 24(1):69-74. PubMed ID: 21190922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
